C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof

Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637)
10/2006
10/31/2006	US7128911 Virus-like particle, and an antigen or antigenic determinant of a receptor activator factor kappa beta ligand protein, fragment or peptide
10/26/2006	WO2006113372A2 Porcine circovirus and helicobacter combination vaccines
10/26/2006	WO2006076343A8 Mycobacteria expressing hiv-1 and malaria antigens
10/26/2006	WO2006075996A3 Reporter plasmid phage packaging system for detection of bacteria
10/26/2006	WO2006055331A9 Porcine reproductive and respiratory syndrome virus strains and compositions
10/26/2006	WO2005080556A9 Virus purification methods
10/26/2006	US20060242734 Insecticidal polypeptides and methods of use thereof
10/26/2006	US20060240538 Cell separation method using alumina
10/26/2006	US20060240530 cDNA of a severe acute respiratory syndrome (SARS) coronavirus, recombinant SARS coronavirus vectors, and SARS coronavirus replicon particles
10/26/2006	US20060240446 Novel human cytomegalovirus DNA sequences
10/26/2006	US20060240041 PRRSV Vaccines
10/26/2006	US20060239967 Oncolytic virus replicating selectively in tumor cells
10/26/2006	CA2605025A1 Viral nucleoprotein detection using an ion channel switch biosensor
10/26/2006	CA2604691A1 Method for porcine circovirus production and assays for monitoring production
10/25/2006	EP1715048A1 Process for producing virus vector
10/25/2006	EP1715046A2 New polypeptide, DNA encoding the polypeptide, recombinant vector bearing the DNA and recombinant virus utilizing the recombinant vector as well as use thereof
10/25/2006	EP1713824A2 Recombinant viruses with heterologous envelope proteins
10/25/2006	EP1292615B1 Modified morbillivirus v proteins
10/25/2006	EP0973802B1 Synthetic peptides useful in biological assays for detecting infections caused by group o hiv-1 viruses
10/25/2006	CN1281741C Diagnostic reagents and methods for antibody against hepatitis B surface antigen and for antibody against hepatitis B Virus
10/25/2006	CN1281276C Virus vector for transferring gene into renal cells
10/24/2006	US7125971 Full-length genomic RNA of papaya leaf-distortion mosaic virus
10/24/2006	US7125717 Metabolically activated recombinant viral vectors and methods for their preparation and use
10/24/2006	US7125706 Method for the production and purification of adenoviral vectors
10/24/2006	US7125705 Expression vector for use as tool in genetic engineering and gene therapy
10/24/2006	CA2211165C Methods for sensitive detection of reverse transcriptase
10/19/2006	WO2006110689A2 Method of increasing the function of an aav vector
10/19/2006	WO2006109174A2 Hiv vaccine comprising a glycoprotein 120 signal sequence with no more than one positively charged amino acid
10/19/2006	WO2006108846A1 Process of manufacturing viral vaccines in suspension avian embryonic derived stem cell lines
10/19/2006	WO2006108707A1 Virus purification using ultrafiltration
10/19/2006	US20060234965 Novel full-length genomic rna of Japanese encephalitis virus, infectious jev cdna therefrom, and use thereof
10/19/2006	US20060234213 Synthetic peptides useful in biological essays for detecting infections caused by group O HIV-1 viruses
10/19/2006	US20060234212 Hepatitis-B viral variants with reduced susceptibility to nucleoside analogs and uses thereof
10/19/2006	US20060233834 Production of poxviruses with adherent or non adherent avian cell lines
10/19/2006	US20060233756 Recombinant adenoviral vectors and applications thereof
10/19/2006	US20060233753 Administering an adenovirus defective in its VAI and VAII virus-associated RNAs
10/19/2006	CA2604538A1 Hiv vaccine
10/19/2006	CA2604330A1 Process of manufacturing viral vaccines in suspension avian embryonic derived stem cell lines
10/19/2006	CA2603863A1 Gammaretrovirus associated with cancer
10/19/2006	CA2602944A1 Virus purification using ultrafiltration
10/18/2006	EP1711619A2 Integrated viral complexes, methods of production thereof, vaccines containing same and methods of use thereof
10/18/2006	EP1711518A2 Chimpanzee adenovirus vaccine carriers
10/18/2006	EP1711513A2 Nanofiltration of factor vii solutions to remove virus
10/18/2006	EP1711204A1 Monoparaimmunity inducers based on attenuated rabbit myxoma viruses
10/18/2006	EP1407006B9 Method for the recovery and purification of poxviruses from infected cells
10/18/2006	EP1183383B1 Siv-based packaging-deficient vectors
10/18/2006	EP1155119B1 Bhv-1 gene-deleted virus vaccine
10/18/2006	EP1079868B1 Apparatus for inactivating contaminants in biological fluid
10/18/2006	EP1003533B1 Use of herpes vectors for tumor therapy
10/18/2006	EP0969862B1 Synthetic hiv gag genes
10/18/2006	EP0939828B1 Herpesvirus saimiri as viral vector
10/18/2006	CN1849134A Functional influenza virus-like particles(VLPs)
10/17/2006	US7122347 A chimeric Arterivirus composed of parts originating from at least two different arteriviruses where a stretch of nucleic acids encoding a non-Arteriviris protein fragment is inserted in the full genome; vaccines; veterinary medicine; swine
10/17/2006	US7122192 Porcine circoviruses, vaccines and diagnostic reagents
10/17/2006	US7122188 For use in diagnostic method for the detection of infection in humans more particularly the absence or presence of antibodies to proteins of the lymphadenopathy retrovirus (LAV), especially the p18 and/or the p25 proteins
10/17/2006	US7122182 Treating cancer in humans; obtain human, administer antitumor agent, evaluate tumor response to antitumor agents
10/17/2006	CA2359659C Method for quality control of an attenuated varicella live vaccine
10/12/2006	WO2006105597A1 Variants of hepatitis b virus with resistance to anti-viral nucleoside agents and applications thereof
10/12/2006	US20060228700 Novel retrovirus associated with myelodysplastic syndromes and uses thereof
10/12/2006	US20060228697 Generating viral replicon having an increased replication activity in a Huh7 cells using variant viral coding sequences; prevention and treatment of liver inflammation, infection and failure
10/12/2006	US20060228376 Virosome-like-particles
10/12/2006	US20060228334 Modified adenoviral fiber with ablated to cellular receptors
10/11/2006	EP1710300A1 Highly safe smallpox vaccine virus and vaccinia virus vector
10/11/2006	EP1710252A2 Flea head, nerve cord, hindgut and malpighian tubule nucleic acid molecules, proteins and uses thereof
10/11/2006	EP1709162A2 A novel process of hepatitis a vaccine preparation
10/11/2006	EP1708748A2 Influenza immunogen and vaccine
10/11/2006	EP1154827B1 Purification of biological substances
10/11/2006	EP1070118B1 Modified adenovirus containing a fiber replacement protein
10/11/2006	EP0490972B2 Recombinant negative strand rna virus expression systems and vaccines
10/11/2006	CN1846000A HPV CD8+ T-cell epitopes
10/11/2006	CN1844376A Recombinant herpes simplex virus type 2 and its preparing method and use
10/11/2006	CN1279165C Inflenza vaccine composition
10/10/2006	US7118879 Obtaining a gene encoding a potential binding domain by random mutagenesis of a few predetermined codons, fusing it to a genetic element, causing the resulting chimeric expression product to be displayed on the outer surface of a cell/virus
10/10/2006	US7118872 Used in detection, isolation, and/or purification
10/10/2006	US7118866 Heterodimeric receptor libraries using phagemids
10/10/2006	US7118740 Method for limiting the growth of cancer cells using an attenuated measles virus
10/10/2006	US7118675 Fluid flow filtration; chromatography; ultrafiltration membrane
10/10/2006	CA2192324C Recombinant virus and related method of quantitating same
10/05/2006	WO2005086658A3 Processes for adenovirus purification using continuous flow centrifugation
10/05/2006	US20060223990 Synthesis, deprotection, analysis & purification of RNA & ribozymes
10/05/2006	US20060223143 Methods and compositions for polypeptide engineering
10/05/2006	US20060222664 Transforming tobacco cell line containing sequences encoding antigens (such as hemagglutinin/neuraminidase protein from Newcastle Disease Virus), culturing, washing, suspending in lysis buffer, disrupting cells, then separating debris; vaccines
10/05/2006	US20060222661 Infectious hepacivirus pseudo-particles containing functional e1, e2 envelope proteins
10/05/2006	US20060222659 Circovirus sequences associated with piglet weight loss disease (PWD)
10/05/2006	US20060222632 Disinfection of foodstuffs
10/05/2006	US20060222630 Internal ribosome entry site of the labial gene for protein expression
10/05/2006	CA2598884A1 Influenza nucleic acids, polypeptides, and uses thereof
10/04/2006	EP1707631A2 An improved method for the production and purification of adenoviral vectors
10/04/2006	EP1706486A1 Chimeric empty capsids of the infectious bursal disease virus (ibdv), obtainment process and applications
10/04/2006	EP1706485A1 EMPTY CAPSIDS (VLPs(-VP4)) OF THE INFECTIOUS BURSAL DISEASE VIRUS (IBDV), OBTAINMENT PROCESS AND APPLICATIONS
10/04/2006	EP1706153A1 Minimal lentiviral vector system
10/04/2006	EP1706152A2 Particle-induced ghrelin immune response
10/04/2006	EP1161537B1 Non-spreading pestivirus
10/04/2006	EP1135513B1 Adenovirus-mediated gene therapy
10/04/2006	EP1054955B1 Compositions comprising viruses and methods for concentrating virus preparations
10/04/2006	EP0689601B1 Production of high titer helper-free retroviruses by transient transfection
10/04/2006	CN1840658A Recombinant adeno-associated virus expressing neuroprotective peptide and its preparation method and application
10/04/2006	CN1840656A Methods to culture circovirus
10/04/2006	CN1840204A Lentiviral vectors for the preparation of immunotherapeutical compositions
10/04/2006	CN1277925C Recombinant Baculovirus for expressing CTB and human insulin fusion protein and use thereof

1 ... 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 ... 267